A Newly Identified Int22h1/Int22h2‐Mediated Xq28 Duplication Syndrome Case Misdiagnosed as Cerebral Palsy

Paulo André Dias Bastos; Raquel Barbosa

doi:10.1055/s-0042-1743435

Journal of Pediatric Neurology, Inhaltsverzeichnis

Journal of Pediatric Neurology 2023; 21(05): 360-364
DOI: 10.1055/s-0042-1743435

Case Report

A Newly Identified Int22h1/Int22h2‐Mediated Xq28 Duplication Syndrome Case Misdiagnosed as Cerebral Palsy

Paulo André Dias Bastos

¹Chronic Diseases Research Centre, NOVA Medical School, Faculty of Medical Sciences, Universidade Nova de Lisboa, Lisbon, Portugal

²Department of Neurology, Hospital de Egas Moniz, Centro Hospitalar de Lisboa Ocidental, Lisbon, Portugal

,

Raquel Barbosa

¹Chronic Diseases Research Centre, NOVA Medical School, Faculty of Medical Sciences, Universidade Nova de Lisboa, Lisbon, Portugal

²Department of Neurology, Hospital de Egas Moniz, Centro Hospitalar de Lisboa Ocidental, Lisbon, Portugal

› Institutsangaben

Abstract

Cerebral palsy (CP) is a nonprogressive, early-onset neurodevelopmental disorder affecting ∼2 to 3/1,000 children worldwide. It is characterized by movement/postural disabilities accompanied by sensitive, perceptual, cognitive, communicational, behavioral, and musculoskeletal perturbations. Many CP patients are thought to have genetic etiologies overlapping those of other neurodevelopmental conditions. Herein, we reported a newly discovered case (the 36th case to date) of a female patient (misdiagnosed with CP until age 19) with the rare X-linked intellectual disability syndrome resulting from an int22h1/int22h2-mediated Xq28 duplication. A microarray analysis revealed a ∼0.4 Mb duplication within the 154.1 to 154.6 Mb subregion of Xq28 (hg19, CRCh37), confirming a diagnosis of the rare int22h1/int22h2-mediated Xq28 duplication intellectual disability syndrome. Atypical T2 hyperintensities were also observed. This case report builds upon the limited cohort of X-linked intellectual disability syndrome patients and reiterates the growing observations pertaining to the phenotypic overlap between genetic CP cases and other neurodevelopmental disorders.

Keywords

chromosomal anomaly - X-linked intellectual disability - chromosomal microarray analysis - cerebral palsy - gene dosage

Volltext

Referenzen

References
1 Surveillance of Cerebral Palsy in Europe. Surveillance of cerebral palsy in Europe: a collaboration of cerebral palsy surveys and registers. Dev Med Child Neurol 2000; 42 (12) 816-824
2 Korzeniewski SJ, Slaughter J, Lenski M, Haak P, Paneth N. The complex aetiology of cerebral palsy. Nat Rev Neurol 2018; 14 (09) 528-543
3 Lewis SA, Shetty S, Wilson BA. et al. Insights from genetic studies of cerebral palsy. Front Neurol 2021; 11: 625428
4 Matthews AM, Blydt-Hansen I, Al-Jabri B. et al; TIDE BC, United for Metabolic Diseases and the CAUSES Study. Atypical cerebral palsy: genomics analysis enables precision medicine. Genet Med 2019; 21 (07) 1621-1628
5 Petterson B, Stanley F, Henderson D. Cerebral palsy in multiple births in Western Australia: genetic aspects. Am J Med Genet 1990; 37 (03) 346-351
6 Segel R, Ben-Pazi H, Zeligson S. et al. Copy number variations in cryptogenic cerebral palsy. Neurology 2015; 84 (16) 1660-1668
7 Oskoui M, Gazzellone MJ, Thiruvahindrapuram B. et al. Clinically relevant copy number variations detected in cerebral palsy. Nat Commun 2015; 6: 7949
8 Zarrei M, Fehlings DL, Mawjee K. et al. De novo and rare inherited copy-number variations in the hemiplegic form of cerebral palsy. Genet Med 2018; 20 (02) 172-180
9 Corbett MA, van Eyk CL, Webber DL. et al. Pathogenic copy number variants that affect gene expression contribute to genomic burden in cerebral palsy. NPJ Genom Med 2018; 3: 33
10 McMichael G, Bainbridge MN, Haan E. et al. Whole-exome sequencing points to considerable genetic heterogeneity of cerebral palsy. Mol Psychiatry 2015; 20 (02) 176-182
11 Rosello M, Caro-Llopis A, Orellana C. et al. Hidden etiology of cerebral palsy: genetic and clinical heterogeneity and efficient diagnosis by next-generation sequencing. Pediatr Res 2021; 90 (02) 284-288
12 Jin SC, Lewis SA, Bakhtiari S. et al. Mutations disrupting neuritogenesis genes confer risk for cerebral palsy. Nat Genet 2020; 52 (10) 1046-1056
13 Sartwelle TP, Johnston JC. Cerebral palsy litigation: change course or abandon ship. J Child Neurol 2015; 30 (07) 828-841
14 Shevell M. Cerebral palsy to cerebral palsy spectrum disorder: time for a name change?. Neurology 2018; 92 (05) 233-235
15 Pearson TS, Pons R, Ghaoui R, Sue CM. Genetic mimics of cerebral palsy. Mov Disord 2019; 34 (05) 625-636
16 Zouvelou V, Yubero D, Apostolakopoulou L. et al. The genetic etiology in cerebral palsy mimics: the results from a Greek tertiary care center. Eur J Paediatr Neurol 2019; 23 (03) 427-437
17 Appleton RE, Gupta R. Cerebral palsy: not always what it seems. Arch Dis Child 2019; 104 (08) 809-814
18 Nicholl J, Waters W, Mulley JC. et al; Array Referral Consortium. Cognitive deficit and autism spectrum disorders: prospective diagnosis by array CGH. Pathology 2014; 46 (01) 41-45
19 Sandweiss AJ, Brandt VL, Zoghbi HY. Advances in understanding of Rett syndrome and MECP2 duplication syndrome: prospects for future therapies. Lancet Neurol 2020; 19 (08) 689-698
20 Shao L, Akkari Y, Cooley LD. et al; ACMG Laboratory Quality Assurance Committee. Chromosomal microarray analysis, including constitutional and neoplastic disease applications, 2021 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG). Genet Med 2021; 23 (10) 1818-1829
21 Manning M, Hudgins L. American College of Medical Genetics and Genomics (ACMG) Professional Practice and Guidelines Committee. Addendum: array-based technology and recommendations for utilization in medical genetics practice for detection of chromosomal abnormalities. Genet Med 2020; 22 (12) 2126
22 El-Hattab AW, Fang P, Jin W. et al. Int22h-1/int22h-2-mediated Xq28 rearrangements: intellectual disability associated with duplications and in utero male lethality with deletions. J Med Genet 2011; 48 (12) 840-850
23 Lannoy N, Grisart B, Eeckhoudt S. et al. Intron 22 homologous regions are implicated in exons 1-22 duplications of the F8 gene. Eur J Hum Genet 2013; 21 (09) 970-976
24 Vanmarsenille L, Giannandrea M, Fieremans N. et al. Increased dosage of RAB39B affects neuronal development and could explain the cognitive impairment in male patients with distal Xq28 copy number gains. Hum Mutat 2014; 35 (03) 377-383
25 El-Hattab AW, Schaaf CP, Fang P. et al. Clinical characterization of int22h1/int22h2-mediated Xq28 duplication/deletion: new cases and literature review. BMC Med Genet 2015; 16: 12
26 Ballout RA, Dickerson C, Wick MJ. et al. Int22h1/Int22h2-mediated Xq28 duplication syndrome: de novo duplications, prenatal diagnoses, and additional phenotypic features. Hum Mutat 2020; 41 (07) 1238-1249
27 Tuttle C, Boto J, Martin S. et al. Neuroimaging of acute and chronic unilateral and bilateral thalamic lesions. Insights Imaging 2019; 10 (01) 24
28 Yamamoto T, Shimojima K, Shimada S. et al. Clinical impacts of genomic copy number gains at Xq28. Hum Genome Var 2014; 1: 14001
29 Takano K, Liu D, Tarpey P. et al. An X-linked channelopathy with cardiomegaly due to a CLIC2 mutation enhancing ryanodine receptor channel activity. Hum Mol Genet 2012; 21 (20) 4497-4507
30 Mignogna ML, Giannandrea M, Gurgone A. et al. The intellectual disability protein RAB39B selectively regulates GluA2 trafficking to determine synaptic AMPAR composition. Nat Commun 2015; 6: 6504
31 Hakami WS, Hundallah KJ, Tabarki BM. Metabolic and genetic disorders mimicking cerebral palsy. Neurosciences (Riyadh) 2019; 24 (03) 155-163